|
|
|
|
Дата |
|---|
| 21.07.2026 |
| 20.07.2026 |
| 17.07.2026 |
| 16.07.2026 |
| 15.07.2026 |
| 14.07.2026 |
| 13.07.2026 |
| 10.07.2026 |
| 09.07.2026 |
| 08.07.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
249.50
|
246.00
|
250.00
|
246.00
|
|
|
574 203.00
|
|
|
|
|
251.00
|
247.00
|
252.50
|
249.50
|
|
|
1 351 774.55
|
|
|
|
|
252.00
|
247.50
|
253.50
|
249.00
|
|
|
1 850 500.75
|
|
|
|
|
252.00
|
250.50
|
253.00
|
252.50
|
|
|
1 092 447.21
|
|
|
|
|
252.00
|
250.50
|
254.00
|
252.00
|
|
|
1 438 342.62
|
|
|
|
|
252.00
|
248.00
|
252.00
|
251.50
|
|
|
633 457.75
|
|
|
|
|
249.50
|
246.00
|
251.00
|
249.50
|
|
|
991 406.50
|
|
|
|
|
249.00
|
249.00
|
251.00
|
249.50
|
|
|
388 273.75
|
|
|
|
|
252.00
|
247.50
|
252.00
|
249.00
|
|
|
1 686 021.50
|
|
|
|
|
255.50
|
251.00
|
258.00
|
252.00
|
|
|
1 181 965.50
|
|
Период |
|---|
| 2025, регулярные |
| 2024, регулярные |
| 2023, регулярные |
| 2022, регулярные |
| 2021, регулярные |
| 2021, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2018, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
17.06.2026
|
18.06.2026 |
9 CHF |
|
02.07.2025
|
03.07.2025 |
4.9 CHF |
|
07.08.2024
|
08.08.2024 |
7.5 CHF |
|
03.08.2023
|
04.08.2023 |
7.5 CHF |
|
30.08.2022
|
31.08.2022 |
9.7 CHF |
|
07.09.2021
|
08.09.2021 |
12.5 CHF |
|
08.09.2020
|
09.09.2020 |
7.7 CHF |
|
10.09.2019
|
11.09.2019 |
7.5 CHF |
|
19.09.2018
|
20.09.2018 |
1.5 CHF |
|
27.06.2018
|
28.06.2018 |
5.5 CHF |
HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of some twenty five promising companies. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).
